the new york times co. - NYT
NYT
Close Chg Chg %
52.00 1.25 2.40%
Closed Market
53.25
+1.25 (2.40%)
Volume: 1.67M
Last Updated:
Nov 21, 2024, 3:59 PM EDT
Company Overview: the new york times co. - NYT
NYT Key Data
| Open $52.15 | Day Range 51.91 - 53.35 |
| 52 Week Range 41.55 - 57.08 | Market Cap $8.53B |
| Shares Outstanding 163.95M | Public Float 160.26M |
| Beta 1.02 | Rev. Per Employee N/A |
| P/E Ratio 30.79 | EPS $1.70 |
| Yield 96.14% | Dividend $0.13 |
| EX-DIVIDEND DATE Oct 9, 2024 | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.32M |
NYT Performance
| 1 Week | 1.51% | ||
| 1 Month | -3.93% | ||
| 3 Months | -3.25% | ||
| 1 Year | 17.14% | ||
| 5 Years | 70.45% |
NYT Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
12
Full Ratings ➔
About the new york times co. - NYT
The New York Times Co. is a media organization, which engages in creating, collecting, and distributing news and information. It offers news products and other interest-specific products, and related content and services. It offers newspapers, print, and digital products and investments. The firm also manages The New York Times, NYTimes.com, and mobile applications. The company was founded by Henry Jarvis Raymond and George Jones on September 18, 1851, and is headquartered in New York, NY.
NYT At a Glance
The New York Times Co.
620 8th Avenue
New York, New York 10018
| Phone | 1-212-556-1234 | Revenue | 2.43B | |
| Industry | Publishing: Newspapers | Net Income | 232.39M | |
| Sector | Consumer Services | 2023 Sales Growth | 5.105% | |
| Fiscal Year-end | 12 / 2024 | Employees | 5,900 | |
| View SEC Filings |
NYT Valuation
| P/E Current | 30.788 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 34.923 |
| Price to Sales Ratio | 3.345 |
| Price to Book Ratio | 4.572 |
| Price to Cash Flow Ratio | 22.505 |
| Enterprise Value to EBITDA | 19.229 |
| Enterprise Value to Sales | 3.181 |
| Total Debt to Enterprise Value | 0.007 |
NYT Efficiency
| Revenue/Employee | 411,212.203 |
| Income Per Employee | 39,387.627 |
| Receivables Turnover | 9.863 |
| Total Asset Turnover | 0.925 |
NYT Liquidity
| Current Ratio | 1.278 |
| Quick Ratio | 1.278 |
| Cash Ratio | 0.738 |
NYT Profitability
| Gross Margin | 44.967 |
| Operating Margin | 12.612 |
| Pretax Margin | 12.472 |
| Net Margin | 9.578 |
| Return on Assets | 8.856 |
| Return on Equity | 13.828 |
| Return on Total Capital | 12.795 |
| Return on Invested Capital | 13.42 |
NYT Capital Structure
| Total Debt to Total Equity | 3.005 |
| Total Debt to Total Capital | 2.917 |
| Total Debt to Total Assets | 1.952 |
| Long-Term Debt to Equity | 2.433 |
| Long-Term Debt to Total Capital | 2.362 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for The New York Times Co. - NYT
Collapse All in section
| All values USD millions. | 2020 | 2021 | 2022 | 2023 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 1.78B | 2.07B | 2.31B | 2.43B | |
Sales Growth
| -1.58% | +16.33% | +11.25% | +5.10% | |
Cost of Goods Sold (COGS) incl D&A
| 1.02B | 1.10B | 1.29B | 1.34B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 70.70M | 66.99M | 92.58M | 95.35M | |
Depreciation
| - | - | 65.48M | 66.05M | - |
Amortization of Intangibles
| - | - | 27.10M | 29.30M | - |
COGS Growth
| +33.29% | +7.31% | +17.73% | +3.37% | |
Gross Income
| 761.28M | 977.81M | 1.02B | 1.09B | |
Gross Income Growth
| -27.16% | +28.44% | +3.98% | +7.30% | |
Gross Profit Margin
| +42.68% | +47.13% | +44.05% | +44.97% |
| 2020 | 2021 | 2022 | 2023 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 578.42M | 704.92M | 745.69M | 785.60M | |
Research & Development
| 132.43M | 160.87M | 204.19M | 228.80M | |
Other SG&A
| 446.00M | 544.05M | 541.50M | 556.80M | |
SGA Growth
| -33.02% | +21.87% | +5.78% | +5.35% | |
Other Operating Expense
| - | - | 14.99M | (605.00K) | - |
Unusual Expense
| (1.00M) | (7.15M) | 54.09M | 29.71M | |
EBIT after Unusual Expense
| 183.86M | 280.03M | 201.97M | 276.27M | |
Non Operating Income/Expense
| (67.70M) | 11.24M | 34.03M | 27.33M | |
Non-Operating Interest Income
| - | 13.96M | 7.26M | 22.12M | |
Equity in Earnings of Affiliates
| - | - | 5.00M | 2.48M | - |
Interest Expense
| - | 727.00K | 769.00K | 1.01M | |
Interest Expense Growth
| - | -97.14% | +5.78% | -100.00% | |
Gross Interest Expense
| - | 757.00K | 780.00K | 1.01M | |
Interest Capitalized
| - | - | 30.00K | 11.00K | - |
Pretax Income
| 115.43M | 290.50M | 236.00M | 302.59M | |
Pretax Income Growth
| -29.81% | +151.66% | -18.76% | +28.22% | |
Pretax Margin
| +6.47% | +14.00% | +10.22% | +12.47% | |
Income Tax
| 14.60M | 70.53M | 62.09M | 69.84M | |
Income Tax - Current - Domestic
| 28.87M | 75.85M | 106.35M | 87.04M | |
Income Tax - Current - Foreign
| 905.00K | 1.04M | 1.90M | 2.59M | |
Income Tax - Deferred - Domestic
| (15.18M) | (6.36M) | (46.15M) | (19.79M) | |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | 5.00M | 2.48M | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 100.84M | 219.97M | 173.91M | 232.75M | |
Minority Interest Expense
| - | - | 734.00K | 365.00K | - |
Net Income
| 100.10M | 219.97M | 173.91M | 232.39M | |
Net Income Growth
| -28.48% | +119.74% | -20.94% | +33.63% | |
Net Margin Growth
| +5.61% | +10.60% | +7.53% | +9.58% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 100.10M | 219.97M | 173.91M | 232.39M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 100.10M | 219.97M | 173.91M | 232.39M | |
EPS (Basic)
| 0.5995 | 1.3099 | 1.0422 | 1.4108 | |
EPS (Basic) Growth
| -28.88% | +118.50% | -20.44% | +35.37% | |
Basic Shares Outstanding
| 166.97M | 167.93M | 166.87M | 164.72M | |
EPS (Diluted)
| 0.5957 | 1.3052 | 1.0405 | 1.4028 | |
EPS (Diluted) Growth
| -28.69% | +119.10% | -20.28% | +34.82% | |
Diluted Shares Outstanding
| 168.04M | 168.53M | 167.14M | 165.66M | |
EBITDA
| 253.56M | 339.87M | 348.63M | 401.32M | |
EBITDA Growth
| +1.59% | +34.04% | +2.58% | +15.11% | |
EBITDA Margin
| +14.22% | +16.38% | +15.10% | +16.54% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 57.889 | |
| Number of Ratings | 12 | Current Quarters Estimate | 0.753 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 1.89 | |
| Last Quarter’s Earnings | 0.45 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.63 | Next Fiscal Year Estimate | 2.071 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 7 | 3 | 9 | 9 |
| Mean Estimate | 0.75 | 0.35 | 1.89 | 2.07 |
| High Estimates | 0.79 | 0.39 | 1.96 | 2.17 |
| Low Estimate | 0.74 | 0.28 | 1.73 | 1.95 |
| Coefficient of Variance | 2.52 | 16.97 | 4.01 | 3.39 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 6 | 6 | 5 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 6 | 5 | 4 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for The New York Times Co. - NYT
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for The New York Times Co. - NYT
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| May 24, 2024 | R. Anthony Benten SVP, Treasurer & CAO | 38,576 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.98 per share | 1,889,452.48 |
| May 15, 2024 | Meredith Kopit Levien PRESIDENT & CEO; Director | 120,072 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $47.72 per share | 5,729,835.84 |
| Apr 29, 2024 | John Washington Rogers Director | 47,966 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 29, 2024 | Anuradha B. Subramanian Director | 5,865 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 29, 2024 | Manuel Bronstein Director | 14,126 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 29, 2024 | Amanpal S. Bhutani Director | 25,579 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 29, 2024 | Rebecca van Dyck Director | 49,820 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 29, 2024 | Rachel C. Glaser Director | 29,223 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 29, 2024 | Beth Ann Brooke Director | 15,842 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 29, 2024 | Arthur S. Golden Director | 16,572 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 29, 2024 | 1997 Trust (Sulzberger) Director | 4,048 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 29, 2024 | Brian P. McAndrews Director | 16,968 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 29, 2024 | Brian P. McAndrews Director | 52,980 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 23, 2024 | Hays N. Golden Director | 50,696 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 5, 2024 | Arthur Gregg Sulzberger Chairman and Publisher; Director | 100,438 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $43.83 per share | 4,402,197.54 |
| Feb 22, 2024 | David Perpich Director | 20,496 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $43.83 per share | 898,339.68 |
| Feb 22, 2024 | Diane Brayton EVP, GENERAL COUNSEL | 36,201 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $43.83 per share | 1,586,689.83 |
| Feb 22, 2024 | William Bardeen Chief Financial Officer | 5,363 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $43.83 per share | 235,060.29 |
| Feb 22, 2024 | Meredith Kopit Levien PRESIDENT & CEO; Director | 88,380 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $43.83 per share | 3,873,695.40 |
| Feb 22, 2024 | Jacqueline M. Welch EVP and CHRO | 4,987 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $43.83 per share | 218,580.21 |